Global Oligonucleotide Synthesis Reagents Market Growth 2026-2032
The global Oligonucleotide Synthesis Reagents market size is predicted to grow from US$ 936 million in 2025 to US$ 1983 million in 2032; it is expected to grow at a CAGR of 11.3% from 2026 to 2032.
Oligonucleotide synthesis reagents are specialized chemical reagents and functional materials used in the stepwise chemical synthesis of DNA, RNA, and chemically modified oligonucleotides. The market is centered on solid-phase phosphoramidite chemistry, in which phosphoramidites serve as nucleotide building blocks and are used together with activators, capping reagents, oxidation reagents, sulfurizing reagents, deblocking reagents, and synthesis-grade solvents. Commercial products range from research-grade materials to production-grade and GMP-grade reagents designed for scale-up and therapeutic manufacturing. Key applications include research oligonucleotides, molecular diagnostics and genomics, therapeutic oligonucleotide manufacturing, and gene-editing or synthetic-biology workflows. The market is increasingly shaped by requirements for modified phosphoramidites, tighter impurity control, low-water solvent systems, scalable manufacturing, and consistent quality across clinical and commercial production. Thermo Fisher Scientific notes that phosphoramidites can be manufactured from gram scale to metric-ton scale, illustrating the transition of oligonucleotide chemistry from laboratory synthesis toward industrial-scale production.
Key FindingsThe global oligonucleotide synthesis reagents industry had an estimated gross margin of approximately 40%–50% in 2025.Phosphoramidites are the largest product category.Therapeutic oligonucleotide manufacturing is the fastest-growing high-value application.North America and Europe are major supply regions for high-specification products, while China continues to strengthen its large-scale supply capabilities.
A second major trend is the transition from laboratory-scale reagent supply toward industrial-scale manufacturing systems. Large-volume customers increasingly require tighter control of moisture, impurities, lot-to-lot consistency, documentation, packaging, and supply continuity. Thermo Fisher identifies extra-dry solvents, deblocking agents, CAP A and CAP B, activators, oxidizers, and phosphoramidites as core chemicals in the oligonucleotide synthesis cycle, highlighting the increasingly integrated nature of reagent procurement.
Demand is also broadening beyond conventional antisense and siRNA products toward lipid-conjugated oligonucleotides and other next-generation delivery architectures. Agilent and Singapore’s Nucleic Acid Therapeutics Initiative announced a 2026 collaboration focused on lipid-conjugated oligonucleotides, illustrating continued innovation in chemical modification and extrahepatic delivery.
The industry also faces potential long-term technology substitution. Chemical phosphoramidite synthesis remains the dominant commercial route, but chemoenzymatic and enzymatic approaches are developing as alternatives for selected long and complex RNA products. These technologies are more likely to complement than broadly replace phosphoramidite chemistry in the near term.
The value chain is progressively moving toward higher-specification products. Standard solvents and basic cycle reagents generally have lower differentiation, whereas modified phosphoramidites, custom chemistries, GMP-grade materials, and reagents requiring sophisticated analytical control command substantially greater technical value.
By application, therapeutic oligonucleotide manufacturing is gaining importance faster than research applications. Maravai reports that oligonucleotide-related products support therapeutics, in vitro diagnostics, NGS, and CRISPR-based gene editing, demonstrating the broadening downstream application base for synthesis inputs.
Molecular diagnostics, genomics, and gene editing remain strategically important secondary opportunities. These applications support continuous demand for specialty labels, linkers, modified bases, probes, primers, and guide RNA-related synthesis chemistry, providing a diversified demand base beyond pharmaceutical manufacturing.
Europe retains strong capabilities in specialty chemistry and high-purity reagent manufacturing. China is increasing its role in global supply through large-scale phosphoramidite production and broader nucleic-acid raw-material portfolios. Hongene has disclosed phosphoramidite production capacity exceeding 58 tons per year and supplies customers across more than 40 countries and regions, illustrating the increasing global relevance of Chinese manufacturing capacity.
Competition is gradually shifting from simple catalog breadth toward manufacturing scalability, GMP readiness, impurity control, customization capability, and security of supply. As therapeutic applications account for a larger share of incremental demand, suppliers capable of supporting customers from research quantities through clinical and commercial-scale production are likely to strengthen their competitive positions.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide Synthesis Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide Synthesis Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide Synthesis Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Synthesis Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Synthesis Reagents.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Synthesis Reagents market by product type, application, key manufacturers and key regions and countries.
Oligonucleotide synthesis reagents are specialized chemical reagents and functional materials used in the stepwise chemical synthesis of DNA, RNA, and chemically modified oligonucleotides. The market is centered on solid-phase phosphoramidite chemistry, in which phosphoramidites serve as nucleotide building blocks and are used together with activators, capping reagents, oxidation reagents, sulfurizing reagents, deblocking reagents, and synthesis-grade solvents. Commercial products range from research-grade materials to production-grade and GMP-grade reagents designed for scale-up and therapeutic manufacturing. Key applications include research oligonucleotides, molecular diagnostics and genomics, therapeutic oligonucleotide manufacturing, and gene-editing or synthetic-biology workflows. The market is increasingly shaped by requirements for modified phosphoramidites, tighter impurity control, low-water solvent systems, scalable manufacturing, and consistent quality across clinical and commercial production. Thermo Fisher Scientific notes that phosphoramidites can be manufactured from gram scale to metric-ton scale, illustrating the transition of oligonucleotide chemistry from laboratory synthesis toward industrial-scale production.
Key FindingsThe global oligonucleotide synthesis reagents industry had an estimated gross margin of approximately 40%–50% in 2025.Phosphoramidites are the largest product category.Therapeutic oligonucleotide manufacturing is the fastest-growing high-value application.North America and Europe are major supply regions for high-specification products, while China continues to strengthen its large-scale supply capabilities.
Market Trends
The market is shifting from standard DNA and RNA synthesis reagents toward higher-value modified phosphoramidites and more tightly controlled production-grade and GMP-grade materials. Demand is increasing for 2'-modified chemistries, specialty linkers, functional modifiers, sulfurization systems, and customized reagent blends that support therapeutic oligonucleotide development and commercial manufacturing.A second major trend is the transition from laboratory-scale reagent supply toward industrial-scale manufacturing systems. Large-volume customers increasingly require tighter control of moisture, impurities, lot-to-lot consistency, documentation, packaging, and supply continuity. Thermo Fisher identifies extra-dry solvents, deblocking agents, CAP A and CAP B, activators, oxidizers, and phosphoramidites as core chemicals in the oligonucleotide synthesis cycle, highlighting the increasingly integrated nature of reagent procurement.
Market Dynamics
Drivers
The principal growth driver is the expansion of therapeutic oligonucleotide pipelines and commercial manufacturing. Greater use of antisense oligonucleotides, siRNA, CRISPR guide RNA, and other modified nucleic-acid therapeutics directly increases consumption of phosphoramidites and cycle reagents. Agilent is expanding oligonucleotide manufacturing capacity in Colorado through a US$725 million investment, with two additional manufacturing trains scheduled for completion in 2027, reinforcing expectations for continued growth in industrial-scale oligonucleotide production.Restraints
The market remains constrained by demanding purity specifications, moisture sensitivity, complex impurity profiles, qualification requirements, and the high cost of specialty modified phosphoramidites. Scaling from research-grade to GMP-grade production also requires substantial investment in analytical control, quality systems, solvent handling, packaging, and supply-chain qualification.Opportunities
The strongest opportunity lies in GMP-grade and highly modified reagents for therapeutic applications. Suppliers capable of providing customized phosphoramidites, advanced modifiers, sulfurization chemistries, high-purity ancillary reagents, and manufacturing support from early development through commercial scale are positioned in the highest-value portion of the market.Demand is also broadening beyond conventional antisense and siRNA products toward lipid-conjugated oligonucleotides and other next-generation delivery architectures. Agilent and Singapore’s Nucleic Acid Therapeutics Initiative announced a 2026 collaboration focused on lipid-conjugated oligonucleotides, illustrating continued innovation in chemical modification and extrahepatic delivery.
Challenges
A major challenge is maintaining high coupling efficiency and impurity control as oligonucleotide length and chemical complexity increase. Solid-phase synthesis requires repeated detritylation, coupling, oxidation or sulfurization, and capping cycles, meaning small losses in individual reaction efficiency can accumulate across longer sequences.The industry also faces potential long-term technology substitution. Chemical phosphoramidite synthesis remains the dominant commercial route, but chemoenzymatic and enzymatic approaches are developing as alternatives for selected long and complex RNA products. These technologies are more likely to complement than broadly replace phosphoramidite chemistry in the near term.
Industry Chain Analysis
The upstream chain consists of protected nucleosides, phosphorus chemistry intermediates, specialty organic chemicals, solvents, protecting groups, and functional modifiers. Midstream suppliers convert these materials into phosphoramidites and ancillary synthesis reagents under increasingly strict purity and quality-control requirements. Downstream customers include oligonucleotide manufacturers and CDMOs, pharmaceutical and biotechnology companies, diagnostics and genomics companies, and academic or research institutions.The value chain is progressively moving toward higher-specification products. Standard solvents and basic cycle reagents generally have lower differentiation, whereas modified phosphoramidites, custom chemistries, GMP-grade materials, and reagents requiring sophisticated analytical control command substantially greater technical value.
Segment Insights
By reagent category, phosphoramidites represent the core value pool, followed by activators, capping reagents, oxidation reagents, sulfurizing reagents, deblocking reagents, and synthesis-grade solvents. Within phosphoramidites, standard DNA and RNA materials form the established base, while 2'-modified, conformationally constrained, and functional modification products constitute the higher-value growth segments.By application, therapeutic oligonucleotide manufacturing is gaining importance faster than research applications. Maravai reports that oligonucleotide-related products support therapeutics, in vitro diagnostics, NGS, and CRISPR-based gene editing, demonstrating the broadening downstream application base for synthesis inputs.
Downstream Market Opportunities
Therapeutic oligonucleotide developers and CDMOs represent the most attractive downstream opportunity because their reagent demand scales with clinical advancement and commercial production volumes. These customers also place greater emphasis on GMP compliance, impurity characterization, change control, traceability, and long-term supply assurance.Molecular diagnostics, genomics, and gene editing remain strategically important secondary opportunities. These applications support continuous demand for specialty labels, linkers, modified bases, probes, primers, and guide RNA-related synthesis chemistry, providing a diversified demand base beyond pharmaceutical manufacturing.
Regional Insights
North America remains an important high-value demand and supply region, supported by therapeutic oligonucleotide development, CDMO capacity, specialty reagent production, diagnostics, genomics, and gene-editing research. Ongoing investment in commercial-scale oligonucleotide manufacturing is reinforcing the region’s demand for GMP-grade phosphoramidites and ancillary reagents.Europe retains strong capabilities in specialty chemistry and high-purity reagent manufacturing. China is increasing its role in global supply through large-scale phosphoramidite production and broader nucleic-acid raw-material portfolios. Hongene has disclosed phosphoramidite production capacity exceeding 58 tons per year and supplies customers across more than 40 countries and regions, illustrating the increasing global relevance of Chinese manufacturing capacity.
Competitive Landscape Analysis
The competitive landscape is characterized by a relatively concentrated group of large-scale and specialist suppliers, supplemented by smaller companies focused on highly modified phosphoramidites or ancillary reagents. North American and European suppliers generally hold advantages in specialty chemistry, high-value modifications, technical support, and established life-science customer networks, while Asian suppliers are strengthening their positions through capacity expansion, manufacturing scale, and increasingly broad product portfolios.Competition is gradually shifting from simple catalog breadth toward manufacturing scalability, GMP readiness, impurity control, customization capability, and security of supply. As therapeutic applications account for a larger share of incremental demand, suppliers capable of supporting customers from research quantities through clinical and commercial-scale production are likely to strengthen their competitive positions.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Oligonucleotide Synthesis Reagents Industry Forecast” looks at past sales and reviews total world Oligonucleotide Synthesis Reagents sales in 2025, providing a comprehensive analysis by region and market sector of projected Oligonucleotide Synthesis Reagents sales for 2026 through 2032. With Oligonucleotide Synthesis Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide Synthesis Reagents industry.This Insight Report provides a comprehensive analysis of the global Oligonucleotide Synthesis Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide Synthesis Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide Synthesis Reagents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide Synthesis Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide Synthesis Reagents.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide Synthesis Reagents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Activators
- Capping Reagents
- Oxidation Reagents
- Sulfurizing Reagents
- Deblocking Reagents
- Others
Segmentation by Phosphoramidite Type:
- Standard DNA Phosphoramidites
- Standard RNA Phosphoramidites
- 2'-Modified Phosphoramidites
- Conformationally Constrained Phosphoramidites
- Functional Modifier and Labeling Phosphoramidites
- Others
Segmentation by Grade:
- Research Grade
- Production Grade
- GMP Grade
- Others
Segmentation by Application:
- Research Oligonucleotide Synthesis
- Molecular Diagnostics and Genomics
- Therapeutic Oligonucleotide Manufacturing
- Gene Editing and Synthetic Biology
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific Inc.
- Maravai LifeSciences Holdings Inc.
- Hongene Biotech Corporation
- Tokyo Chemical Industry Co., Ltd.
- ChemGenes Corporation
- emp BIOTECH GmbH
- PolyOrg Inc.
- Lumiprobe Corporation
- Suzhou GenePoly Co., Ltd.
- Concord Technology Tianjin Co., Ltd.
- Solstice Advanced Materials Inc.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Oligonucleotide Synthesis Reagents market?
- What factors are driving Oligonucleotide Synthesis Reagents market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Oligonucleotide Synthesis Reagents market opportunities vary by end market size?
- How does Oligonucleotide Synthesis Reagents break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide Synthesis Reagents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oligonucleotide Synthesis Reagents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oligonucleotide Synthesis Reagents by Country/Region, 2021, 2025 & 2032
2.2 Oligonucleotide Synthesis Reagents Segment by Type
2.2.1 Activators
2.2.2 Capping Reagents
2.2.3 Oxidation Reagents
2.2.4 Sulfurizing Reagents
2.2.5 Deblocking Reagents
2.2.6 Others
2.2.7 Oligonucleotide Synthesis Reagents Sales by Type
2.2.7.1 Global Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
2.2.7.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Oligonucleotide Synthesis Reagents Sale Price by Type (2021-2026)
2.3 Oligonucleotide Synthesis Reagents Segment by Phosphoramidite Type
2.3.1 Standard DNA Phosphoramidites
2.3.2 Standard RNA Phosphoramidites
2.3.3 2'-Modified Phosphoramidites
2.3.4 Conformationally Constrained Phosphoramidites
2.3.5 Functional Modifier and Labeling Phosphoramidites
2.3.6 Others
2.3.7 Oligonucleotide Synthesis Reagents Sales by Phosphoramidite Type
2.3.7.1 Global Oligonucleotide Synthesis Reagents Sales Market Share by Phosphoramidite Type (2021-2026)
2.3.7.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Phosphoramidite Type (2021-2026)
2.3.7.3 Global Oligonucleotide Synthesis Reagents Sale Price by Phosphoramidite Type (2021-2026)
2.4 Oligonucleotide Synthesis Reagents Segment by Grade
2.4.1 Research Grade
2.4.2 Production Grade
2.4.3 GMP Grade
2.4.4 Others
2.4.5 Oligonucleotide Synthesis Reagents Sales by Grade
2.4.5.1 Global Oligonucleotide Synthesis Reagents Sales Market Share by Grade (2021-2026)
2.4.5.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Grade (2021-2026)
2.4.5.3 Global Oligonucleotide Synthesis Reagents Sale Price by Grade (2021-2026)
2.5 Oligonucleotide Synthesis Reagents Segment by Application
2.5.1 Research Oligonucleotide Synthesis
2.5.2 Molecular Diagnostics and Genomics
2.5.3 Therapeutic Oligonucleotide Manufacturing
2.5.4 Gene Editing and Synthetic Biology
2.5.5 Others
2.5.6 Oligonucleotide Synthesis Reagents Sales by Application
2.5.6.1 Global Oligonucleotide Synthesis Reagents Sale Market Share by Application (2021-2026)
2.5.6.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Oligonucleotide Synthesis Reagents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oligonucleotide Synthesis Reagents Breakdown Data by Company
3.1.1 Global Oligonucleotide Synthesis Reagents Annual Sales by Company (2021-2026)
3.1.2 Global Oligonucleotide Synthesis Reagents Sales Market Share by Company (2021-2026)
3.2 Global Oligonucleotide Synthesis Reagents Annual Revenue by Company (2021-2026)
3.2.1 Global Oligonucleotide Synthesis Reagents Revenue by Company (2021-2026)
3.2.2 Global Oligonucleotide Synthesis Reagents Revenue Market Share by Company (2021-2026)
3.3 Global Oligonucleotide Synthesis Reagents Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Synthesis Reagents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Synthesis Reagents Product Location Distribution
3.4.2 Players Oligonucleotide Synthesis Reagents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OLIGONUCLEOTIDE SYNTHESIS REAGENTS BY GEOGRAPHIC REGION
4.1 World Historic Oligonucleotide Synthesis Reagents Market Size by Geographic Region (2021-2026)
4.1.1 Global Oligonucleotide Synthesis Reagents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oligonucleotide Synthesis Reagents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oligonucleotide Synthesis Reagents Market Size by Country/Region (2021-2026)
4.2.1 Global Oligonucleotide Synthesis Reagents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oligonucleotide Synthesis Reagents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oligonucleotide Synthesis Reagents Sales Growth
4.4 APAC Oligonucleotide Synthesis Reagents Sales Growth
4.5 Europe Oligonucleotide Synthesis Reagents Sales Growth
4.6 Middle East & Africa Oligonucleotide Synthesis Reagents Sales Growth
5 AMERICAS
5.1 Americas Oligonucleotide Synthesis Reagents Sales by Country
5.1.1 Americas Oligonucleotide Synthesis Reagents Sales by Country (2021-2026)
5.1.2 Americas Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026)
5.2 Americas Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
5.3 Americas Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Synthesis Reagents Sales by Region
6.1.1 APAC Oligonucleotide Synthesis Reagents Sales by Region (2021-2026)
6.1.2 APAC Oligonucleotide Synthesis Reagents Revenue by Region (2021-2026)
6.2 APAC Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
6.3 APAC Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oligonucleotide Synthesis Reagents by Country
7.1.1 Europe Oligonucleotide Synthesis Reagents Sales by Country (2021-2026)
7.1.2 Europe Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026)
7.2 Europe Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
7.3 Europe Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide Synthesis Reagents by Country
8.1.1 Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026)
8.2 Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
8.3 Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide Synthesis Reagents
10.3 Manufacturing Process Analysis of Oligonucleotide Synthesis Reagents
10.4 Industry Chain Structure of Oligonucleotide Synthesis Reagents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Synthesis Reagents Distributors
11.3 Oligonucleotide Synthesis Reagents Customer
12 WORLD FORECAST REVIEW FOR OLIGONUCLEOTIDE SYNTHESIS REAGENTS BY GEOGRAPHIC REGION
12.1 Global Oligonucleotide Synthesis Reagents Market Size Forecast by Region
12.1.1 Global Oligonucleotide Synthesis Reagents Forecast by Region (2027-2032)
12.1.2 Global Oligonucleotide Synthesis Reagents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oligonucleotide Synthesis Reagents Forecast by Type (2027-2032)
12.7 Global Oligonucleotide Synthesis Reagents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 Maravai LifeSciences Holdings Inc.
13.2.1 Maravai LifeSciences Holdings Inc. Company Information
13.2.2 Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.2.3 Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Maravai LifeSciences Holdings Inc. Main Business Overview
13.2.5 Maravai LifeSciences Holdings Inc. Latest Developments
13.3 Hongene Biotech Corporation
13.3.1 Hongene Biotech Corporation Company Information
13.3.2 Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.3.3 Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hongene Biotech Corporation Main Business Overview
13.3.5 Hongene Biotech Corporation Latest Developments
13.4 Tokyo Chemical Industry Co., Ltd.
13.4.1 Tokyo Chemical Industry Co., Ltd. Company Information
13.4.2 Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.4.3 Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Tokyo Chemical Industry Co., Ltd. Main Business Overview
13.4.5 Tokyo Chemical Industry Co., Ltd. Latest Developments
13.5 ChemGenes Corporation
13.5.1 ChemGenes Corporation Company Information
13.5.2 ChemGenes Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.5.3 ChemGenes Corporation Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ChemGenes Corporation Main Business Overview
13.5.5 ChemGenes Corporation Latest Developments
13.6 emp BIOTECH GmbH
13.6.1 emp BIOTECH GmbH Company Information
13.6.2 emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.6.3 emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 emp BIOTECH GmbH Main Business Overview
13.6.5 emp BIOTECH GmbH Latest Developments
13.7 PolyOrg Inc.
13.7.1 PolyOrg Inc. Company Information
13.7.2 PolyOrg Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.7.3 PolyOrg Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 PolyOrg Inc. Main Business Overview
13.7.5 PolyOrg Inc. Latest Developments
13.8 Lumiprobe Corporation
13.8.1 Lumiprobe Corporation Company Information
13.8.2 Lumiprobe Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.8.3 Lumiprobe Corporation Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lumiprobe Corporation Main Business Overview
13.8.5 Lumiprobe Corporation Latest Developments
13.9 Suzhou GenePoly Co., Ltd.
13.9.1 Suzhou GenePoly Co., Ltd. Company Information
13.9.2 Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.9.3 Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Suzhou GenePoly Co., Ltd. Main Business Overview
13.9.5 Suzhou GenePoly Co., Ltd. Latest Developments
13.10 Concord Technology Tianjin Co., Ltd.
13.10.1 Concord Technology Tianjin Co., Ltd. Company Information
13.10.2 Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.10.3 Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Concord Technology Tianjin Co., Ltd. Main Business Overview
13.10.5 Concord Technology Tianjin Co., Ltd. Latest Developments
13.11 Solstice Advanced Materials Inc.
13.11.1 Solstice Advanced Materials Inc. Company Information
13.11.2 Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.11.3 Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Solstice Advanced Materials Inc. Main Business Overview
13.11.5 Solstice Advanced Materials Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide Synthesis Reagents Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Oligonucleotide Synthesis Reagents by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Oligonucleotide Synthesis Reagents by Country/Region, 2021, 2025 & 2032
2.2 Oligonucleotide Synthesis Reagents Segment by Type
2.2.1 Activators
2.2.2 Capping Reagents
2.2.3 Oxidation Reagents
2.2.4 Sulfurizing Reagents
2.2.5 Deblocking Reagents
2.2.6 Others
2.2.7 Oligonucleotide Synthesis Reagents Sales by Type
2.2.7.1 Global Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
2.2.7.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Type (2021-2026)
2.2.7.3 Global Oligonucleotide Synthesis Reagents Sale Price by Type (2021-2026)
2.3 Oligonucleotide Synthesis Reagents Segment by Phosphoramidite Type
2.3.1 Standard DNA Phosphoramidites
2.3.2 Standard RNA Phosphoramidites
2.3.3 2'-Modified Phosphoramidites
2.3.4 Conformationally Constrained Phosphoramidites
2.3.5 Functional Modifier and Labeling Phosphoramidites
2.3.6 Others
2.3.7 Oligonucleotide Synthesis Reagents Sales by Phosphoramidite Type
2.3.7.1 Global Oligonucleotide Synthesis Reagents Sales Market Share by Phosphoramidite Type (2021-2026)
2.3.7.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Phosphoramidite Type (2021-2026)
2.3.7.3 Global Oligonucleotide Synthesis Reagents Sale Price by Phosphoramidite Type (2021-2026)
2.4 Oligonucleotide Synthesis Reagents Segment by Grade
2.4.1 Research Grade
2.4.2 Production Grade
2.4.3 GMP Grade
2.4.4 Others
2.4.5 Oligonucleotide Synthesis Reagents Sales by Grade
2.4.5.1 Global Oligonucleotide Synthesis Reagents Sales Market Share by Grade (2021-2026)
2.4.5.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Grade (2021-2026)
2.4.5.3 Global Oligonucleotide Synthesis Reagents Sale Price by Grade (2021-2026)
2.5 Oligonucleotide Synthesis Reagents Segment by Application
2.5.1 Research Oligonucleotide Synthesis
2.5.2 Molecular Diagnostics and Genomics
2.5.3 Therapeutic Oligonucleotide Manufacturing
2.5.4 Gene Editing and Synthetic Biology
2.5.5 Others
2.5.6 Oligonucleotide Synthesis Reagents Sales by Application
2.5.6.1 Global Oligonucleotide Synthesis Reagents Sale Market Share by Application (2021-2026)
2.5.6.2 Global Oligonucleotide Synthesis Reagents Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Oligonucleotide Synthesis Reagents Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Oligonucleotide Synthesis Reagents Breakdown Data by Company
3.1.1 Global Oligonucleotide Synthesis Reagents Annual Sales by Company (2021-2026)
3.1.2 Global Oligonucleotide Synthesis Reagents Sales Market Share by Company (2021-2026)
3.2 Global Oligonucleotide Synthesis Reagents Annual Revenue by Company (2021-2026)
3.2.1 Global Oligonucleotide Synthesis Reagents Revenue by Company (2021-2026)
3.2.2 Global Oligonucleotide Synthesis Reagents Revenue Market Share by Company (2021-2026)
3.3 Global Oligonucleotide Synthesis Reagents Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Synthesis Reagents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Synthesis Reagents Product Location Distribution
3.4.2 Players Oligonucleotide Synthesis Reagents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OLIGONUCLEOTIDE SYNTHESIS REAGENTS BY GEOGRAPHIC REGION
4.1 World Historic Oligonucleotide Synthesis Reagents Market Size by Geographic Region (2021-2026)
4.1.1 Global Oligonucleotide Synthesis Reagents Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Oligonucleotide Synthesis Reagents Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Oligonucleotide Synthesis Reagents Market Size by Country/Region (2021-2026)
4.2.1 Global Oligonucleotide Synthesis Reagents Annual Sales by Country/Region (2021-2026)
4.2.2 Global Oligonucleotide Synthesis Reagents Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oligonucleotide Synthesis Reagents Sales Growth
4.4 APAC Oligonucleotide Synthesis Reagents Sales Growth
4.5 Europe Oligonucleotide Synthesis Reagents Sales Growth
4.6 Middle East & Africa Oligonucleotide Synthesis Reagents Sales Growth
5 AMERICAS
5.1 Americas Oligonucleotide Synthesis Reagents Sales by Country
5.1.1 Americas Oligonucleotide Synthesis Reagents Sales by Country (2021-2026)
5.1.2 Americas Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026)
5.2 Americas Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
5.3 Americas Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Synthesis Reagents Sales by Region
6.1.1 APAC Oligonucleotide Synthesis Reagents Sales by Region (2021-2026)
6.1.2 APAC Oligonucleotide Synthesis Reagents Revenue by Region (2021-2026)
6.2 APAC Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
6.3 APAC Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oligonucleotide Synthesis Reagents by Country
7.1.1 Europe Oligonucleotide Synthesis Reagents Sales by Country (2021-2026)
7.1.2 Europe Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026)
7.2 Europe Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
7.3 Europe Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide Synthesis Reagents by Country
8.1.1 Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Country (2021-2026)
8.1.2 Middle East & Africa Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026)
8.2 Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Type (2021-2026)
8.3 Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide Synthesis Reagents
10.3 Manufacturing Process Analysis of Oligonucleotide Synthesis Reagents
10.4 Industry Chain Structure of Oligonucleotide Synthesis Reagents
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Synthesis Reagents Distributors
11.3 Oligonucleotide Synthesis Reagents Customer
12 WORLD FORECAST REVIEW FOR OLIGONUCLEOTIDE SYNTHESIS REAGENTS BY GEOGRAPHIC REGION
12.1 Global Oligonucleotide Synthesis Reagents Market Size Forecast by Region
12.1.1 Global Oligonucleotide Synthesis Reagents Forecast by Region (2027-2032)
12.1.2 Global Oligonucleotide Synthesis Reagents Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Oligonucleotide Synthesis Reagents Forecast by Type (2027-2032)
12.7 Global Oligonucleotide Synthesis Reagents Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific Inc.
13.1.1 Thermo Fisher Scientific Inc. Company Information
13.1.2 Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Thermo Fisher Scientific Inc. Main Business Overview
13.1.5 Thermo Fisher Scientific Inc. Latest Developments
13.2 Maravai LifeSciences Holdings Inc.
13.2.1 Maravai LifeSciences Holdings Inc. Company Information
13.2.2 Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.2.3 Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Maravai LifeSciences Holdings Inc. Main Business Overview
13.2.5 Maravai LifeSciences Holdings Inc. Latest Developments
13.3 Hongene Biotech Corporation
13.3.1 Hongene Biotech Corporation Company Information
13.3.2 Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.3.3 Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hongene Biotech Corporation Main Business Overview
13.3.5 Hongene Biotech Corporation Latest Developments
13.4 Tokyo Chemical Industry Co., Ltd.
13.4.1 Tokyo Chemical Industry Co., Ltd. Company Information
13.4.2 Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.4.3 Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Tokyo Chemical Industry Co., Ltd. Main Business Overview
13.4.5 Tokyo Chemical Industry Co., Ltd. Latest Developments
13.5 ChemGenes Corporation
13.5.1 ChemGenes Corporation Company Information
13.5.2 ChemGenes Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.5.3 ChemGenes Corporation Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 ChemGenes Corporation Main Business Overview
13.5.5 ChemGenes Corporation Latest Developments
13.6 emp BIOTECH GmbH
13.6.1 emp BIOTECH GmbH Company Information
13.6.2 emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.6.3 emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 emp BIOTECH GmbH Main Business Overview
13.6.5 emp BIOTECH GmbH Latest Developments
13.7 PolyOrg Inc.
13.7.1 PolyOrg Inc. Company Information
13.7.2 PolyOrg Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.7.3 PolyOrg Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 PolyOrg Inc. Main Business Overview
13.7.5 PolyOrg Inc. Latest Developments
13.8 Lumiprobe Corporation
13.8.1 Lumiprobe Corporation Company Information
13.8.2 Lumiprobe Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.8.3 Lumiprobe Corporation Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Lumiprobe Corporation Main Business Overview
13.8.5 Lumiprobe Corporation Latest Developments
13.9 Suzhou GenePoly Co., Ltd.
13.9.1 Suzhou GenePoly Co., Ltd. Company Information
13.9.2 Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.9.3 Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Suzhou GenePoly Co., Ltd. Main Business Overview
13.9.5 Suzhou GenePoly Co., Ltd. Latest Developments
13.10 Concord Technology Tianjin Co., Ltd.
13.10.1 Concord Technology Tianjin Co., Ltd. Company Information
13.10.2 Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.10.3 Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Concord Technology Tianjin Co., Ltd. Main Business Overview
13.10.5 Concord Technology Tianjin Co., Ltd. Latest Developments
13.11 Solstice Advanced Materials Inc.
13.11.1 Solstice Advanced Materials Inc. Company Information
13.11.2 Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
13.11.3 Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Solstice Advanced Materials Inc. Main Business Overview
13.11.5 Solstice Advanced Materials Inc. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oligonucleotide Synthesis Reagents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oligonucleotide Synthesis Reagents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Activators
Table 4. Major Players of Capping Reagents
Table 5. Major Players of Oxidation Reagents
Table 6. Major Players of Sulfurizing Reagents
Table 7. Major Players of Deblocking Reagents
Table 8. Major Players of Others
Table 9. Global Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 10. Global Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Table 11. Global Oligonucleotide Synthesis Reagents Revenue by Type (2021-2026) & ($ million)
Table 12. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Type (2021-2026)
Table 13. Global Oligonucleotide Synthesis Reagents Sale Price by Type (2021-2026) & (US$/kg)
Table 14. Major Players of Standard DNA Phosphoramidites
Table 15. Major Players of Standard RNA Phosphoramidites
Table 16. Major Players of 2'-Modified Phosphoramidites
Table 17. Major Players of Conformationally Constrained Phosphoramidites
Table 18. Major Players of Functional Modifier and Labeling Phosphoramidites
Table 19. Major Players of Others
Table 20. Global Oligonucleotide Synthesis Reagents Sales by Phosphoramidite Type (2021-2026) & (Tons)
Table 21. Global Oligonucleotide Synthesis Reagents Sales Market Share by Phosphoramidite Type (2021-2026)
Table 22. Global Oligonucleotide Synthesis Reagents Revenue by Phosphoramidite Type (2021-2026) & ($ million)
Table 23. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Phosphoramidite Type (2021-2026)
Table 24. Global Oligonucleotide Synthesis Reagents Sale Price by Phosphoramidite Type (2021-2026) & (US$/kg)
Table 25. Major Players of Research Grade
Table 26. Major Players of Production Grade
Table 27. Major Players of GMP Grade
Table 28. Major Players of Others
Table 29. Global Oligonucleotide Synthesis Reagents Sales by Grade (2021-2026) & (Tons)
Table 30. Global Oligonucleotide Synthesis Reagents Sales Market Share by Grade (2021-2026)
Table 31. Global Oligonucleotide Synthesis Reagents Revenue by Grade (2021-2026) & ($ million)
Table 32. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Grade (2021-2026)
Table 33. Global Oligonucleotide Synthesis Reagents Sale Price by Grade (2021-2026) & (US$/kg)
Table 34. Global Oligonucleotide Synthesis Reagents Sale by Application (2021-2026) & (Tons)
Table 35. Global Oligonucleotide Synthesis Reagents Sale Market Share by Application (2021-2026)
Table 36. Global Oligonucleotide Synthesis Reagents Revenue by Application (2021-2026) & ($ million)
Table 37. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Application (2021-2026)
Table 38. Global Oligonucleotide Synthesis Reagents Sale Price by Application (2021-2026) & (US$/kg)
Table 39. Global Oligonucleotide Synthesis Reagents Sales by Company (2021-2026) & (Tons)
Table 40. Global Oligonucleotide Synthesis Reagents Sales Market Share by Company (2021-2026)
Table 41. Global Oligonucleotide Synthesis Reagents Revenue by Company (2021-2026) & ($ millions)
Table 42. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Company (2021-2026)
Table 43. Global Oligonucleotide Synthesis Reagents Sale Price by Company (2021-2026) & (US$/kg)
Table 44. Key Manufacturers Oligonucleotide Synthesis Reagents Producing Area Distribution and Sales Area
Table 45. Players Oligonucleotide Synthesis Reagents Products Offered
Table 46. Oligonucleotide Synthesis Reagents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 47. New Products and Potential Entrants
Table 48. Market M&A Activity & Strategy
Table 49. Global Oligonucleotide Synthesis Reagents Sales by Geographic Region (2021-2026) & (Tons)
Table 50. Global Oligonucleotide Synthesis Reagents Sales Market Share Geographic Region (2021-2026)
Table 51. Global Oligonucleotide Synthesis Reagents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 52. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Geographic Region (2021-2026)
Table 53. Global Oligonucleotide Synthesis Reagents Sales by Country/Region (2021-2026) & (Tons)
Table 54. Global Oligonucleotide Synthesis Reagents Sales Market Share by Country/Region (2021-2026)
Table 55. Global Oligonucleotide Synthesis Reagents Revenue by Country/Region (2021-2026) & ($ millions)
Table 56. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Country/Region (2021-2026)
Table 57. Americas Oligonucleotide Synthesis Reagents Sales by Country (2021-2026) & (Tons)
Table 58. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Country (2021-2026)
Table 59. Americas Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026) & ($ millions)
Table 60. Americas Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 61. Americas Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 62. APAC Oligonucleotide Synthesis Reagents Sales by Region (2021-2026) & (Tons)
Table 63. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Region (2021-2026)
Table 64. APAC Oligonucleotide Synthesis Reagents Revenue by Region (2021-2026) & ($ millions)
Table 65. APAC Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 66. APAC Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 67. Europe Oligonucleotide Synthesis Reagents Sales by Country (2021-2026) & (Tons)
Table 68. Europe Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026) & ($ millions)
Table 69. Europe Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 70. Europe Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 71. Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Country (2021-2026) & (Tons)
Table 72. Middle East & Africa Oligonucleotide Synthesis Reagents Revenue Market Share by Country (2021-2026)
Table 73. Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 74. Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 75. Key Market Drivers & Growth Opportunities of Oligonucleotide Synthesis Reagents
Table 76. Key Market Challenges & Risks of Oligonucleotide Synthesis Reagents
Table 77. Key Industry Trends of Oligonucleotide Synthesis Reagents
Table 78. Oligonucleotide Synthesis Reagents Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Oligonucleotide Synthesis Reagents Distributors List
Table 81. Oligonucleotide Synthesis Reagents Customer List
Table 82. Global Oligonucleotide Synthesis Reagents Sales Forecast by Region (2027-2032) & (Tons)
Table 83. Global Oligonucleotide Synthesis Reagents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Americas Oligonucleotide Synthesis Reagents Sales Forecast by Country (2027-2032) & (Tons)
Table 85. Americas Oligonucleotide Synthesis Reagents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. APAC Oligonucleotide Synthesis Reagents Sales Forecast by Region (2027-2032) & (Tons)
Table 87. APAC Oligonucleotide Synthesis Reagents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 88. Europe Oligonucleotide Synthesis Reagents Sales Forecast by Country (2027-2032) & (Tons)
Table 89. Europe Oligonucleotide Synthesis Reagents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Forecast by Country (2027-2032) & (Tons)
Table 91. Middle East & Africa Oligonucleotide Synthesis Reagents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Global Oligonucleotide Synthesis Reagents Sales Forecast by Type (2027-2032) & (Tons)
Table 93. Global Oligonucleotide Synthesis Reagents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 94. Global Oligonucleotide Synthesis Reagents Sales Forecast by Application (2027-2032) & (Tons)
Table 95. Global Oligonucleotide Synthesis Reagents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 96. Thermo Fisher Scientific Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 97. Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 98. Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Thermo Fisher Scientific Inc. Main Business
Table 100. Thermo Fisher Scientific Inc. Latest Developments
Table 101. Maravai LifeSciences Holdings Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 102. Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 103. Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Maravai LifeSciences Holdings Inc. Main Business
Table 105. Maravai LifeSciences Holdings Inc. Latest Developments
Table 106. Hongene Biotech Corporation Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 107. Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 108. Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Hongene Biotech Corporation Main Business
Table 110. Hongene Biotech Corporation Latest Developments
Table 111. Tokyo Chemical Industry Co., Ltd. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 112. Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 113. Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Tokyo Chemical Industry Co., Ltd. Main Business
Table 115. Tokyo Chemical Industry Co., Ltd. Latest Developments
Table 116. ChemGenes Corporation Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 117. ChemGenes Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 118. ChemGenes Corporation Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. ChemGenes Corporation Main Business
Table 120. ChemGenes Corporation Latest Developments
Table 121. emp BIOTECH GmbH Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 122. emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 123. emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. emp BIOTECH GmbH Main Business
Table 125. emp BIOTECH GmbH Latest Developments
Table 126. PolyOrg Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 127. PolyOrg Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 128. PolyOrg Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. PolyOrg Inc. Main Business
Table 130. PolyOrg Inc. Latest Developments
Table 131. Lumiprobe Corporation Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 132. Lumiprobe Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 133. Lumiprobe Corporation Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Lumiprobe Corporation Main Business
Table 135. Lumiprobe Corporation Latest Developments
Table 136. Suzhou GenePoly Co., Ltd. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 137. Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 138. Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Suzhou GenePoly Co., Ltd. Main Business
Table 140. Suzhou GenePoly Co., Ltd. Latest Developments
Table 141. Concord Technology Tianjin Co., Ltd. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 142. Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 143. Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Concord Technology Tianjin Co., Ltd. Main Business
Table 145. Concord Technology Tianjin Co., Ltd. Latest Developments
Table 146. Solstice Advanced Materials Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 147. Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 148. Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Solstice Advanced Materials Inc. Main Business
Table 150. Solstice Advanced Materials Inc. Latest Developments
Table 1. Oligonucleotide Synthesis Reagents Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Oligonucleotide Synthesis Reagents Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Activators
Table 4. Major Players of Capping Reagents
Table 5. Major Players of Oxidation Reagents
Table 6. Major Players of Sulfurizing Reagents
Table 7. Major Players of Deblocking Reagents
Table 8. Major Players of Others
Table 9. Global Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 10. Global Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Table 11. Global Oligonucleotide Synthesis Reagents Revenue by Type (2021-2026) & ($ million)
Table 12. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Type (2021-2026)
Table 13. Global Oligonucleotide Synthesis Reagents Sale Price by Type (2021-2026) & (US$/kg)
Table 14. Major Players of Standard DNA Phosphoramidites
Table 15. Major Players of Standard RNA Phosphoramidites
Table 16. Major Players of 2'-Modified Phosphoramidites
Table 17. Major Players of Conformationally Constrained Phosphoramidites
Table 18. Major Players of Functional Modifier and Labeling Phosphoramidites
Table 19. Major Players of Others
Table 20. Global Oligonucleotide Synthesis Reagents Sales by Phosphoramidite Type (2021-2026) & (Tons)
Table 21. Global Oligonucleotide Synthesis Reagents Sales Market Share by Phosphoramidite Type (2021-2026)
Table 22. Global Oligonucleotide Synthesis Reagents Revenue by Phosphoramidite Type (2021-2026) & ($ million)
Table 23. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Phosphoramidite Type (2021-2026)
Table 24. Global Oligonucleotide Synthesis Reagents Sale Price by Phosphoramidite Type (2021-2026) & (US$/kg)
Table 25. Major Players of Research Grade
Table 26. Major Players of Production Grade
Table 27. Major Players of GMP Grade
Table 28. Major Players of Others
Table 29. Global Oligonucleotide Synthesis Reagents Sales by Grade (2021-2026) & (Tons)
Table 30. Global Oligonucleotide Synthesis Reagents Sales Market Share by Grade (2021-2026)
Table 31. Global Oligonucleotide Synthesis Reagents Revenue by Grade (2021-2026) & ($ million)
Table 32. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Grade (2021-2026)
Table 33. Global Oligonucleotide Synthesis Reagents Sale Price by Grade (2021-2026) & (US$/kg)
Table 34. Global Oligonucleotide Synthesis Reagents Sale by Application (2021-2026) & (Tons)
Table 35. Global Oligonucleotide Synthesis Reagents Sale Market Share by Application (2021-2026)
Table 36. Global Oligonucleotide Synthesis Reagents Revenue by Application (2021-2026) & ($ million)
Table 37. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Application (2021-2026)
Table 38. Global Oligonucleotide Synthesis Reagents Sale Price by Application (2021-2026) & (US$/kg)
Table 39. Global Oligonucleotide Synthesis Reagents Sales by Company (2021-2026) & (Tons)
Table 40. Global Oligonucleotide Synthesis Reagents Sales Market Share by Company (2021-2026)
Table 41. Global Oligonucleotide Synthesis Reagents Revenue by Company (2021-2026) & ($ millions)
Table 42. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Company (2021-2026)
Table 43. Global Oligonucleotide Synthesis Reagents Sale Price by Company (2021-2026) & (US$/kg)
Table 44. Key Manufacturers Oligonucleotide Synthesis Reagents Producing Area Distribution and Sales Area
Table 45. Players Oligonucleotide Synthesis Reagents Products Offered
Table 46. Oligonucleotide Synthesis Reagents Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 47. New Products and Potential Entrants
Table 48. Market M&A Activity & Strategy
Table 49. Global Oligonucleotide Synthesis Reagents Sales by Geographic Region (2021-2026) & (Tons)
Table 50. Global Oligonucleotide Synthesis Reagents Sales Market Share Geographic Region (2021-2026)
Table 51. Global Oligonucleotide Synthesis Reagents Revenue by Geographic Region (2021-2026) & ($ millions)
Table 52. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Geographic Region (2021-2026)
Table 53. Global Oligonucleotide Synthesis Reagents Sales by Country/Region (2021-2026) & (Tons)
Table 54. Global Oligonucleotide Synthesis Reagents Sales Market Share by Country/Region (2021-2026)
Table 55. Global Oligonucleotide Synthesis Reagents Revenue by Country/Region (2021-2026) & ($ millions)
Table 56. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Country/Region (2021-2026)
Table 57. Americas Oligonucleotide Synthesis Reagents Sales by Country (2021-2026) & (Tons)
Table 58. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Country (2021-2026)
Table 59. Americas Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026) & ($ millions)
Table 60. Americas Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 61. Americas Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 62. APAC Oligonucleotide Synthesis Reagents Sales by Region (2021-2026) & (Tons)
Table 63. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Region (2021-2026)
Table 64. APAC Oligonucleotide Synthesis Reagents Revenue by Region (2021-2026) & ($ millions)
Table 65. APAC Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 66. APAC Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 67. Europe Oligonucleotide Synthesis Reagents Sales by Country (2021-2026) & (Tons)
Table 68. Europe Oligonucleotide Synthesis Reagents Revenue by Country (2021-2026) & ($ millions)
Table 69. Europe Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 70. Europe Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 71. Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Country (2021-2026) & (Tons)
Table 72. Middle East & Africa Oligonucleotide Synthesis Reagents Revenue Market Share by Country (2021-2026)
Table 73. Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Type (2021-2026) & (Tons)
Table 74. Middle East & Africa Oligonucleotide Synthesis Reagents Sales by Application (2021-2026) & (Tons)
Table 75. Key Market Drivers & Growth Opportunities of Oligonucleotide Synthesis Reagents
Table 76. Key Market Challenges & Risks of Oligonucleotide Synthesis Reagents
Table 77. Key Industry Trends of Oligonucleotide Synthesis Reagents
Table 78. Oligonucleotide Synthesis Reagents Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Oligonucleotide Synthesis Reagents Distributors List
Table 81. Oligonucleotide Synthesis Reagents Customer List
Table 82. Global Oligonucleotide Synthesis Reagents Sales Forecast by Region (2027-2032) & (Tons)
Table 83. Global Oligonucleotide Synthesis Reagents Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Americas Oligonucleotide Synthesis Reagents Sales Forecast by Country (2027-2032) & (Tons)
Table 85. Americas Oligonucleotide Synthesis Reagents Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. APAC Oligonucleotide Synthesis Reagents Sales Forecast by Region (2027-2032) & (Tons)
Table 87. APAC Oligonucleotide Synthesis Reagents Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 88. Europe Oligonucleotide Synthesis Reagents Sales Forecast by Country (2027-2032) & (Tons)
Table 89. Europe Oligonucleotide Synthesis Reagents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Forecast by Country (2027-2032) & (Tons)
Table 91. Middle East & Africa Oligonucleotide Synthesis Reagents Revenue Forecast by Country (2027-2032) & ($ millions)
Table 92. Global Oligonucleotide Synthesis Reagents Sales Forecast by Type (2027-2032) & (Tons)
Table 93. Global Oligonucleotide Synthesis Reagents Revenue Forecast by Type (2027-2032) & ($ millions)
Table 94. Global Oligonucleotide Synthesis Reagents Sales Forecast by Application (2027-2032) & (Tons)
Table 95. Global Oligonucleotide Synthesis Reagents Revenue Forecast by Application (2027-2032) & ($ millions)
Table 96. Thermo Fisher Scientific Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 97. Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 98. Thermo Fisher Scientific Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 99. Thermo Fisher Scientific Inc. Main Business
Table 100. Thermo Fisher Scientific Inc. Latest Developments
Table 101. Maravai LifeSciences Holdings Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 102. Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 103. Maravai LifeSciences Holdings Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 104. Maravai LifeSciences Holdings Inc. Main Business
Table 105. Maravai LifeSciences Holdings Inc. Latest Developments
Table 106. Hongene Biotech Corporation Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 107. Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 108. Hongene Biotech Corporation Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 109. Hongene Biotech Corporation Main Business
Table 110. Hongene Biotech Corporation Latest Developments
Table 111. Tokyo Chemical Industry Co., Ltd. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 112. Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 113. Tokyo Chemical Industry Co., Ltd. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 114. Tokyo Chemical Industry Co., Ltd. Main Business
Table 115. Tokyo Chemical Industry Co., Ltd. Latest Developments
Table 116. ChemGenes Corporation Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 117. ChemGenes Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 118. ChemGenes Corporation Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 119. ChemGenes Corporation Main Business
Table 120. ChemGenes Corporation Latest Developments
Table 121. emp BIOTECH GmbH Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 122. emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 123. emp BIOTECH GmbH Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 124. emp BIOTECH GmbH Main Business
Table 125. emp BIOTECH GmbH Latest Developments
Table 126. PolyOrg Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 127. PolyOrg Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 128. PolyOrg Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 129. PolyOrg Inc. Main Business
Table 130. PolyOrg Inc. Latest Developments
Table 131. Lumiprobe Corporation Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 132. Lumiprobe Corporation Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 133. Lumiprobe Corporation Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 134. Lumiprobe Corporation Main Business
Table 135. Lumiprobe Corporation Latest Developments
Table 136. Suzhou GenePoly Co., Ltd. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 137. Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 138. Suzhou GenePoly Co., Ltd. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 139. Suzhou GenePoly Co., Ltd. Main Business
Table 140. Suzhou GenePoly Co., Ltd. Latest Developments
Table 141. Concord Technology Tianjin Co., Ltd. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 142. Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 143. Concord Technology Tianjin Co., Ltd. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 144. Concord Technology Tianjin Co., Ltd. Main Business
Table 145. Concord Technology Tianjin Co., Ltd. Latest Developments
Table 146. Solstice Advanced Materials Inc. Basic Information, Oligonucleotide Synthesis Reagents Manufacturing Base, Sales Area and Its Competitors
Table 147. Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Product Portfolios and Specifications
Table 148. Solstice Advanced Materials Inc. Oligonucleotide Synthesis Reagents Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 149. Solstice Advanced Materials Inc. Main Business
Table 150. Solstice Advanced Materials Inc. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oligonucleotide Synthesis Reagents
Figure 2. Oligonucleotide Synthesis Reagents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oligonucleotide Synthesis Reagents Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Oligonucleotide Synthesis Reagents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oligonucleotide Synthesis Reagents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oligonucleotide Synthesis Reagents Sales Market Share by Country/Region (2025)
Figure 10. Oligonucleotide Synthesis Reagents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Activators
Figure 12. Product Picture of Capping Reagents
Figure 13. Product Picture of Oxidation Reagents
Figure 14. Product Picture of Sulfurizing Reagents
Figure 15. Product Picture of Deblocking Reagents
Figure 16. Product Picture of Others
Figure 17. Global Oligonucleotide Synthesis Reagents Sales Market Share by Type in 2026
Figure 18. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Standard DNA Phosphoramidites
Figure 20. Product Picture of Standard RNA Phosphoramidites
Figure 21. Product Picture of 2'-Modified Phosphoramidites
Figure 22. Product Picture of Conformationally Constrained Phosphoramidites
Figure 23. Product Picture of Functional Modifier and Labeling Phosphoramidites
Figure 24. Product Picture of Others
Figure 25. Global Oligonucleotide Synthesis Reagents Sales Market Share by Phosphoramidite Type in 2026
Figure 26. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Phosphoramidite Type (2021-2026)
Figure 27. Product Picture of Research Grade
Figure 28. Product Picture of Production Grade
Figure 29. Product Picture of GMP Grade
Figure 30. Product Picture of Others
Figure 31. Global Oligonucleotide Synthesis Reagents Sales Market Share by Grade in 2026
Figure 32. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Grade (2021-2026)
Figure 33. Oligonucleotide Synthesis Reagents Consumed in Research Oligonucleotide Synthesis
Figure 34. Global Oligonucleotide Synthesis Reagents Market: Research Oligonucleotide Synthesis (2021-2026) & (Tons)
Figure 35. Oligonucleotide Synthesis Reagents Consumed in Molecular Diagnostics and Genomics
Figure 36. Global Oligonucleotide Synthesis Reagents Market: Molecular Diagnostics and Genomics (2021-2026) & (Tons)
Figure 37. Oligonucleotide Synthesis Reagents Consumed in Therapeutic Oligonucleotide Manufacturing
Figure 38. Global Oligonucleotide Synthesis Reagents Market: Therapeutic Oligonucleotide Manufacturing (2021-2026) & (Tons)
Figure 39. Oligonucleotide Synthesis Reagents Consumed in Gene Editing and Synthetic Biology
Figure 40. Global Oligonucleotide Synthesis Reagents Market: Gene Editing and Synthetic Biology (2021-2026) & (Tons)
Figure 41. Oligonucleotide Synthesis Reagents Consumed in Others
Figure 42. Global Oligonucleotide Synthesis Reagents Market: Others (2021-2026) & (Tons)
Figure 43. Global Oligonucleotide Synthesis Reagents Sale Market Share by Application (2025)
Figure 44. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Application in 2025
Figure 45. Oligonucleotide Synthesis Reagents Sales by Company in 2025 (Tons)
Figure 46. Global Oligonucleotide Synthesis Reagents Sales Market Share by Company in 2025
Figure 47. Oligonucleotide Synthesis Reagents Revenue by Company in 2025 ($ millions)
Figure 48. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Company in 2025
Figure 49. Global Oligonucleotide Synthesis Reagents Sales Market Share by Geographic Region (2021-2026)
Figure 50. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Geographic Region in 2025
Figure 51. Americas Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 52. Americas Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 53. APAC Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 54. APAC Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 55. Europe Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 56. Europe Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 57. Middle East & Africa Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 58. Middle East & Africa Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 59. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Country in 2025
Figure 60. Americas Oligonucleotide Synthesis Reagents Revenue Market Share by Country (2021-2026)
Figure 61. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 62. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 63. United States Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 64. Canada Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 65. Mexico Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 66. Brazil Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 67. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Region in 2025
Figure 68. APAC Oligonucleotide Synthesis Reagents Revenue Market Share by Region (2021-2026)
Figure 69. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 70. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 71. China Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 72. Japan Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Korea Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 74. Southeast Asia Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 75. India Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 76. Australia Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 77. China Taiwan Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 78. Europe Oligonucleotide Synthesis Reagents Sales Market Share by Country in 2025
Figure 79. Europe Oligonucleotide Synthesis Reagents Revenue Market Share by Country (2021-2026)
Figure 80. Europe Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 81. Europe Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 82. Germany Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 83. France Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 84. UK Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 85. Italy Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 86. Russia Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 87. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Market Share by Country (2021-2026)
Figure 88. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 89. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 90. Egypt Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 91. South Africa Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 92. Israel Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 93. Turkey Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 94. GCC Countries Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 95. Manufacturing Cost Structure Analysis of Oligonucleotide Synthesis Reagents in 2026
Figure 96. Manufacturing Process Analysis of Oligonucleotide Synthesis Reagents
Figure 97. Industry Chain Structure of Oligonucleotide Synthesis Reagents
Figure 98. Channels of Distribution
Figure 99. Global Oligonucleotide Synthesis Reagents Sales Market Forecast by Region (2027-2032)
Figure 100. Global Oligonucleotide Synthesis Reagents Revenue Market Share Forecast by Region (2027-2032)
Figure 101. Global Oligonucleotide Synthesis Reagents Sales Market Share Forecast by Type (2027-2032)
Figure 102. Global Oligonucleotide Synthesis Reagents Revenue Market Share Forecast by Type (2027-2032)
Figure 103. Global Oligonucleotide Synthesis Reagents Sales Market Share Forecast by Application (2027-2032)
Figure 104. Global Oligonucleotide Synthesis Reagents Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Oligonucleotide Synthesis Reagents
Figure 2. Oligonucleotide Synthesis Reagents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oligonucleotide Synthesis Reagents Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Oligonucleotide Synthesis Reagents Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Oligonucleotide Synthesis Reagents Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Oligonucleotide Synthesis Reagents Sales Market Share by Country/Region (2025)
Figure 10. Oligonucleotide Synthesis Reagents Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Activators
Figure 12. Product Picture of Capping Reagents
Figure 13. Product Picture of Oxidation Reagents
Figure 14. Product Picture of Sulfurizing Reagents
Figure 15. Product Picture of Deblocking Reagents
Figure 16. Product Picture of Others
Figure 17. Global Oligonucleotide Synthesis Reagents Sales Market Share by Type in 2026
Figure 18. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Type (2021-2026)
Figure 19. Product Picture of Standard DNA Phosphoramidites
Figure 20. Product Picture of Standard RNA Phosphoramidites
Figure 21. Product Picture of 2'-Modified Phosphoramidites
Figure 22. Product Picture of Conformationally Constrained Phosphoramidites
Figure 23. Product Picture of Functional Modifier and Labeling Phosphoramidites
Figure 24. Product Picture of Others
Figure 25. Global Oligonucleotide Synthesis Reagents Sales Market Share by Phosphoramidite Type in 2026
Figure 26. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Phosphoramidite Type (2021-2026)
Figure 27. Product Picture of Research Grade
Figure 28. Product Picture of Production Grade
Figure 29. Product Picture of GMP Grade
Figure 30. Product Picture of Others
Figure 31. Global Oligonucleotide Synthesis Reagents Sales Market Share by Grade in 2026
Figure 32. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Grade (2021-2026)
Figure 33. Oligonucleotide Synthesis Reagents Consumed in Research Oligonucleotide Synthesis
Figure 34. Global Oligonucleotide Synthesis Reagents Market: Research Oligonucleotide Synthesis (2021-2026) & (Tons)
Figure 35. Oligonucleotide Synthesis Reagents Consumed in Molecular Diagnostics and Genomics
Figure 36. Global Oligonucleotide Synthesis Reagents Market: Molecular Diagnostics and Genomics (2021-2026) & (Tons)
Figure 37. Oligonucleotide Synthesis Reagents Consumed in Therapeutic Oligonucleotide Manufacturing
Figure 38. Global Oligonucleotide Synthesis Reagents Market: Therapeutic Oligonucleotide Manufacturing (2021-2026) & (Tons)
Figure 39. Oligonucleotide Synthesis Reagents Consumed in Gene Editing and Synthetic Biology
Figure 40. Global Oligonucleotide Synthesis Reagents Market: Gene Editing and Synthetic Biology (2021-2026) & (Tons)
Figure 41. Oligonucleotide Synthesis Reagents Consumed in Others
Figure 42. Global Oligonucleotide Synthesis Reagents Market: Others (2021-2026) & (Tons)
Figure 43. Global Oligonucleotide Synthesis Reagents Sale Market Share by Application (2025)
Figure 44. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Application in 2025
Figure 45. Oligonucleotide Synthesis Reagents Sales by Company in 2025 (Tons)
Figure 46. Global Oligonucleotide Synthesis Reagents Sales Market Share by Company in 2025
Figure 47. Oligonucleotide Synthesis Reagents Revenue by Company in 2025 ($ millions)
Figure 48. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Company in 2025
Figure 49. Global Oligonucleotide Synthesis Reagents Sales Market Share by Geographic Region (2021-2026)
Figure 50. Global Oligonucleotide Synthesis Reagents Revenue Market Share by Geographic Region in 2025
Figure 51. Americas Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 52. Americas Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 53. APAC Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 54. APAC Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 55. Europe Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 56. Europe Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 57. Middle East & Africa Oligonucleotide Synthesis Reagents Sales 2021-2026 (Tons)
Figure 58. Middle East & Africa Oligonucleotide Synthesis Reagents Revenue 2021-2026 ($ millions)
Figure 59. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Country in 2025
Figure 60. Americas Oligonucleotide Synthesis Reagents Revenue Market Share by Country (2021-2026)
Figure 61. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 62. Americas Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 63. United States Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 64. Canada Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 65. Mexico Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 66. Brazil Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 67. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Region in 2025
Figure 68. APAC Oligonucleotide Synthesis Reagents Revenue Market Share by Region (2021-2026)
Figure 69. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 70. APAC Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 71. China Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 72. Japan Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 73. South Korea Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 74. Southeast Asia Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 75. India Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 76. Australia Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 77. China Taiwan Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 78. Europe Oligonucleotide Synthesis Reagents Sales Market Share by Country in 2025
Figure 79. Europe Oligonucleotide Synthesis Reagents Revenue Market Share by Country (2021-2026)
Figure 80. Europe Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 81. Europe Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 82. Germany Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 83. France Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 84. UK Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 85. Italy Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 86. Russia Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 87. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Market Share by Country (2021-2026)
Figure 88. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Market Share by Type (2021-2026)
Figure 89. Middle East & Africa Oligonucleotide Synthesis Reagents Sales Market Share by Application (2021-2026)
Figure 90. Egypt Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 91. South Africa Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 92. Israel Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 93. Turkey Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 94. GCC Countries Oligonucleotide Synthesis Reagents Revenue Growth 2021-2026 ($ millions)
Figure 95. Manufacturing Cost Structure Analysis of Oligonucleotide Synthesis Reagents in 2026
Figure 96. Manufacturing Process Analysis of Oligonucleotide Synthesis Reagents
Figure 97. Industry Chain Structure of Oligonucleotide Synthesis Reagents
Figure 98. Channels of Distribution
Figure 99. Global Oligonucleotide Synthesis Reagents Sales Market Forecast by Region (2027-2032)
Figure 100. Global Oligonucleotide Synthesis Reagents Revenue Market Share Forecast by Region (2027-2032)
Figure 101. Global Oligonucleotide Synthesis Reagents Sales Market Share Forecast by Type (2027-2032)
Figure 102. Global Oligonucleotide Synthesis Reagents Revenue Market Share Forecast by Type (2027-2032)
Figure 103. Global Oligonucleotide Synthesis Reagents Sales Market Share Forecast by Application (2027-2032)
Figure 104. Global Oligonucleotide Synthesis Reagents Revenue Market Share Forecast by Application (2027-2032)
